CARM Carisma Therapeutics Inc.
Fundamentals / CIK 0001485003 / USDCarisma Therapeutics Inc. reported $52.60M in revenue and net income of $8.04M for the trailing twelve months ended September 30, 2025 (up 1232.4% year over year), with a 20.6% operating margin.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open CARM in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue TTM$52.60M +1232.4% YoY
-
Operating Income TTM$10.85M 20.6% margin
-
Net Income TTM$8.04M 15.3% net margin
-
Diluted EPS TTM$0.19 Split-adjusted
-
Free Cash Flow TTM-$22.41M -42.6% FCF margin
-
Cash & ST Investments Sep 30, 2025$2.78M Total debt: $762K
Annual revenue and net income
10 fiscal years (2015 to 2024), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $19.60M | $14.90M | $9.80M | $26.54M | $11.24M | $0 | $0 | $0 | $406K | $490K |
| Research & Development | $59.67M | $74.12M | $56.62M | $25.31M | $29.19M | $24.66M | $14.08M | $12.51M | $13.48M | $26.34M |
| Total Operating Expenses | $81.81M | $103.7M | $66.00M | $35.09M | $32.31M | $108.5M | $34.50M | $29.68M | $27.11M | $36.19M |
| Operating Income | -$62.18M | -$88.73M | -$56.16M | -$8.55M | -$21.08M | -$108.5M | -$34.50M | -$29.25M | $2.87M | -$35.20M |
| EBITDA | -$58.83M | -$85.89M | -$54.27M | -$8.46M | -$20.95M | -$108.3M | -$34.29M | -$28.97M | $3.04M | -$34.83M |
| Interest Income | -- | -- | $1.85M | $17K | $224K | -- | -- | -- | -- | -- |
| Interest Expense | -- | -- | -- | -- | -- | -- | -- | -- | -- | $0 |
| Income Before Tax | -- | -- | -$23.76M | -$8.61M | -$20.95M | -$107.5M | -$33.69M | -$29.03M | $1.90M | -$33.45M |
| Income Tax Expense | -- | -- | -$3.88M | -$8.27M | $1.45M | $0 | $0 | $0 | $5.0K | $0 |
| Net Income | -$60.48M | -$86.88M | -$61.23M | -$336K | -$22.40M | -$107.5M | -$33.69M | -$29.03M | $1.89M | -$33.45M |
| Basic EPS | -$1.46 | -$2.59 | -$28.77 | $0.00 | -$0.19 | -$1.18 | -$0.55 | -$1.11 | $0.09 | -$1.76 |
| Diluted EPS | -$1.46 | -$2.59 | -$28.77 | $0.00 | -$0.19 | -$1.18 | -$0.55 | -$1.11 | $0.09 | -$1.76 |
| Basic Shares Outstanding | 41.5M | 33.5M | 2.1M | 182.3M | 118.2M | 90.9M | 61.8M | 26.1M | 21.1M | 19.0M |
| Diluted Shares Outstanding | 41.5M | 33.5M | 2.1M | 182.3M | 118.2M | 90.9M | 61.8M | 26.1M | 21.7M | 19.0M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $45.30M | $0 | $3.70M | $3.60M | $3.40M | $9.20M | $3.40M | $4.30M |
| Research & Development | $197K | $2.42M | $9.16M | $15.58M | $11.33M | $15.31M | $17.46M | $19.41M |
| Total Operating Expenses | $1.44M | $5.78M | $13.06M | $21.51M | $16.53M | $20.87M | $22.91M | $26.74M |
| Operating Income | $43.81M | -$5.78M | -$9.33M | -$17.86M | -$13.14M | -$11.67M | -$19.51M | -$22.45M |
| EBITDA | $43.81M | -$5.78M | -$8.67M | -$17.19M | -$12.41M | -$11.41M | -$17.82M | -$21.73M |
| Income Tax Expense | $0 | $0 | $0 | -- | $0 | $0 | $0 | -- |
| Net Income | $44.72M | -$9.77M | -$9.27M | -$17.64M | -$12.70M | -$11.16M | -$18.98M | -$20.96M |
| Basic EPS | $1.07 | -$0.23 | -$0.22 | -- | -$0.31 | -$0.27 | -$0.46 | -- |
| Diluted EPS | $1.07 | -$0.23 | -$0.22 | -- | -$0.31 | -$0.27 | -$0.46 | -- |
| Basic Shares Outstanding | 41.8M | 41.8M | 41.8M | -- | 41.6M | 41.5M | 40.9M | -- |
| Diluted Shares Outstanding | 41.9M | 41.8M | 41.8M | -- | 41.6M | 41.5M | 40.9M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $17.91M | $77.61M | $24.19M | $162.6M | $52.39M | $48.12M | $50.42M | $14.68M | $25.34M | $36.08M |
| Short-Term Investments | -- | $0 | $27.80M | $0 | -- | -- | -- | -- | -- | -- |
| Cash & Short-Term Investments | $17.90M | $77.60M | $166.9M | $162.6M | $52.39M | $48.12M | $50.42M | $14.68M | $25.34M | $36.08M |
| Accounts Receivable, Net | -- | -- | $0 | $21.01M | $0 | -- | -- | -- | -- | -- |
| Total Current Assets | $23.82M | $80.47M | $54.59M | $205.6M | $62.87M | $54.45M | $51.76M | $14.98M | $25.93M | $36.31M |
| Property, Plant & Equipment, Net | $4.38M | $6.76M | $8.63M | $43K | $123K | $238K | $321K | $522K | $796K | $407K |
| Goodwill | -- | -- | $0 | $13.06M | $13.06M | $13.06M | $13.06M | $13.06M | $16.86M | $0 |
| Intangible Assets | -- | -- | $0 | $14.70M | $46.40M | $46.40M | $46.40M | $46.40M | $60.50M | $0 |
| Long-Term Investments | -- | -- | -- | $0 | -- | -- | -- | -- | -- | -- |
| Other Non-Current Assets | -- | -- | $0 | $123K | $349K | $196K | $0 | $120K | $0 | $13K |
| Total Non-Current Assets | $6.63M | $9.08M | $30K | $35.14M | $59.96M | $59.92M | $59.80M | $60.12M | $78.17M | $514K |
| Total Assets | $30.46M | $89.55M | $72.15M | $240.7M | $122.8M | $114.4M | $111.6M | $75.10M | $104.1M | $36.83M |
| Accounts Payable | $2.08M | $3.93M | $1.73M | $2.85M | $3.10M | $1.90M | $1.37M | $907K | $1.67M | $1.25M |
| Deferred Revenue (Current) | $3.73M | $1.41M | $2.46M | $0 | $1.50M | $0 | -- | $0 | $425K | $406K |
| Other Current Liabilities | $1.06M | $965K | $523K | $460K | $489K | $446K | $0 | -- | -- | $0 |
| Total Current Liabilities | $16.05M | $15.91M | $19.67M | $11.57M | $18.05M | $8.52M | $6.11M | $4.72M | $3.98M | $7.58M |
| Deferred Revenue (Non-Current) | $41.25M | $45.00M | $0 | $1.50M | $1.50M | $0 | -- | -- | -- | -- |
| Other Non-Current Liabilities | $318K | $926K | $1.04M | $0 | $118K | $0 | $313K | $215K | $0 | $423K |
| Total Non-Current Liabilities | $42.31M | $47.11M | $0 | $57.47M | $114.0M | $132.5M | $61.24M | $52.34M | $61.44M | $10.30M |
| Total Liabilities | $58.37M | $63.02M | $107.0M | $69.04M | $132.1M | $141.1M | $67.35M | $57.06M | $65.42M | $17.88M |
| Total Debt (incl. Leases) | $2.48M | $3.12M | $6.45M | $124K | $271K | $112K | -- | -- | -- | -- |
| Common Stock | $41K | $40K | $2.0K | $199K | $140K | $107K | $77K | $35K | $25K | $20K |
| Retained Earnings | -$305.6M | -$245.1M | -$158.2M | -$316.3M | -$315.9M | -$293.5M | -$186.0M | -$152.3M | -$123.3M | -$125.2M |
| Accumulated Other Comp. Income | -- | $0 | -$41K | $0 | -- | -- | -- | -- | -- | -- |
| Total Stockholders' Equity | -- | $26.53M | -$157.1M | $171.7M | -$9.23M | -$26.70M | $44.21M | $18.03M | $38.68M | $18.94M |
| Total Equity | -$27.91M | $26.53M | -$142.7M | -$81.78M | -$9.23M | -$26.70M | $44.21M | $18.03M | $38.68M | $18.94M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $2.78M | $2.00M | $7.74M | $17.91M | $26.88M | $40.36M | $56.52M | $77.61M |
| Short-Term Investments | -- | -- | -- | -- | -- | -- | -- | $0 |
| Cash & Short-Term Investments | $2.80M | $2.00M | $7.70M | $17.90M | $26.90M | $40.40M | $56.50M | $77.60M |
| Total Current Assets | $5.87M | $4.29M | $13.95M | $23.82M | $34.14M | $50.72M | $60.95M | $80.47M |
| Property, Plant & Equipment, Net | $0 | $0 | $0 | $4.38M | $5.39M | $6.53M | $7.55M | $6.76M |
| Total Non-Current Assets | $684K | $717K | $2.00M | $6.63M | $7.92M | $8.62M | $12.84M | $9.08M |
| Total Assets | $6.55M | $5.01M | $15.95M | $30.46M | $42.06M | $59.34M | $73.80M | $89.55M |
| Accounts Payable | $5.57M | $4.76M | $3.25M | $2.08M | $1.73M | $2.03M | $2.17M | $3.93M |
| Deferred Revenue (Current) | $0 | $0 | $0 | $3.73M | $682K | $659K | $1.19M | $1.41M |
| Other Current Liabilities | $0 | $613K | $853K | $1.06M | $1.15M | $1.22M | $1.19M | $965K |
| Total Current Liabilities | $6.81M | $8.95M | $10.45M | $16.05M | $10.56M | $15.62M | $13.14M | $15.91M |
| Deferred Revenue (Non-Current) | $0 | $41.25M | $41.25M | $41.25M | $41.25M | $41.25M | $45.00M | $45.00M |
| Other Non-Current Liabilities | $0 | $169K | $231K | $318K | $519K | $815K | $1.13M | $926K |
| Total Non-Current Liabilities | $609K | $42.07M | $42.17M | $42.31M | $42.63M | $43.36M | $49.76M | $47.11M |
| Total Liabilities | $7.42M | $51.02M | $52.62M | $58.37M | $53.18M | $58.98M | $62.90M | $63.02M |
| Total Debt (incl. Leases) | $762K | $1.70M | $2.33M | $2.48M | $3.32M | $3.76M | $7.49M | $3.12M |
| Common Stock | $41K | $41K | $41K | $41K | $41K | $41K | $41K | $40K |
| Retained Earnings | -$279.9M | -$324.6M | -$314.8M | -$305.6M | -$287.9M | -$275.2M | -$264.1M | -$245.1M |
| Accumulated Other Comp. Income | -- | -- | -- | -- | -- | -- | -- | $0 |
| Total Stockholders' Equity | -- | -- | -- | -- | -- | -- | -- | $26.53M |
| Total Equity | -$867K | -$46.01M | -$36.66M | -$27.91M | -$11.13M | $360K | $10.89M | $26.53M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$60.48M | -$86.88M | -$61.23M | -$336K | -$22.40M | -$107.5M | -$33.69M | -$29.03M | $1.89M | -$33.45M |
| Depreciation & Amortization | $3.35M | $2.84M | $1.89M | $85K | $122K | $219K | $208K | $285K | $178K | $366K |
| Stock-Based Compensation | $3.65M | $2.32M | $275K | $5.14M | $1.76M | $1.24M | $1.28M | $1.38M | $4.01M | $2.53M |
| Change in Receivables | -- | -- | $21.01M | -$24.49M | $0 | $0 | -- | -- | -- | -- |
| Change in Payables | -$1.85M | $2.19M | -$473K | -$249K | $1.20M | $535K | $460K | -$760K | -$742K | -$1.21M |
| Operating Cash Flow | -$59.92M | -$81.18M | -$5.12M | -$68.88M | -$30.84M | -$37.52M | -$22.83M | -$17.77M | $2.54M | -$34.53M |
| Capital Expenditure | -$123K | -$1.13M | -$4.66M | -$4.0K | -$8.0K | -$136K | -$2.0K | -$10K | -- | -$287K |
| Free Cash Flow | -$60.04M | -$82.31M | -$9.78M | -$68.88M | -$30.84M | -$37.66M | -$22.83M | -$17.77M | -- | -$34.82M |
| Purchases of Investments | $0 | -$34.46M | -$129.0M | $0 | $0 | -- | -- | -- | -- | -- |
| Investing Cash Flow | -$123K | $72.41M | -$32.56M | -$4.0K | -$8.0K | -$136K | -$2.0K | $98K | $461K | -$287K |
| Common Stock Issued | $2.39M | $597K | $0 | $175.0M | $37.96M | $1.94M | $0 | $0 | $0 | $12.65M |
| Financing Cash Flow | $344K | $62.18M | $33.32M | $176.1M | $38.11M | $35.36M | $58.58M | $7.00M | -$13.82M | $16.84M |
| Net Change in Cash | -$59.70M | $53.41M | -$29.07M | $107.2M | $7.27M | -$2.30M | $35.75M | -$10.66M | -$10.74M | -$17.98M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | $44.72M | -$9.77M | -$9.27M | -$17.64M | -$12.70M | -$11.16M | -$18.98M | -$20.96M |
| Depreciation & Amortization | $0 | $0 | $661K | $669K | $737K | $255K | $1.69M | $722K |
| Stock-Based Compensation | $421K | $431K | $508K | $852K | $1.11M | $625K | $1.06M | $873K |
| Change in Payables | $1.14M | $781K | $1.17M | $376K | -$328K | -$74K | -$1.83M | $1.82M |
| Operating Cash Flow | $1.91M | -$5.90M | -$10.07M | -$8.35M | -$13.02M | -$16.12M | -$22.43M | -$16.10M |
| Capital Expenditure | $0 | $0 | $0 | $0 | $0 | -$106K | -$17K | -$561K |
| Free Cash Flow | $1.91M | -$5.90M | -$10.07M | -$8.35M | -$13.02M | -$16.23M | -$22.44M | -$16.66M |
| Purchases of Investments | -- | -- | -- | $0 | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $163K | $524K | $0 | $0 | -$106K | -$17K | $10.44M |
| Common Stock Issued | $0 | $0 | $0 | -$23K | $129K | $0 | $2.29M | $597K |
| Financing Cash Flow | -$1.13M | $0 | -$626K | -$620K | -$461K | $73K | $1.35M | $101K |
| Net Change in Cash | $778K | -$5.74M | -$10.17M | -$8.97M | -$13.48M | -$16.15M | -$21.09M | -$5.56M |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -317.2% | -595.5% | -573.1% | -32.2% | -187.6% | -- | -- | -- | 705.9% | -7182.9% |
| Net Profit Margin | -308.6% | -583.1% | -624.8% | -1.3% | -199.3% | -- | -- | -- | 465.8% | -6826.9% |
| Return on Equity (ROE) | -- | -327.4% | -- | -0.2% | -- | -- | -76.2% | -161.0% | 4.9% | -176.6% |
| Return on Assets (ROA) | -198.6% | -97.0% | -84.9% | -0.1% | -18.2% | -94.0% | -30.2% | -38.7% | 1.8% | -90.8% |
| Current Ratio | 1.48x | 5.06x | 2.78x | 17.77x | 3.48x | 6.39x | 8.47x | 3.17x | 6.51x | 4.79x |
| Quick Ratio | 1.11x | 4.88x | 8.49x | 15.88x | 2.90x | 5.65x | 8.25x | 3.11x | 6.37x | 4.76x |
| Debt to Equity | -- | 0.12x | -- | 0.00x | -- | -- | -- | -- | -- | -- |
| Revenue Growth (YoY) | +31.5% | +52.0% | -63.1% | +136.2% | -- | -- | -- | -100.0% | -17.1% | -78.2% |
| Operating Income Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -1120.8% | -- | -- |
| Net Income Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -1635.1% | -- | -- |
| EPS Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -1333.3% | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -800.0% | -- | -- |
| 5Y Revenue / Share Growth | -- | -- | -- | +656.0% | +268.4% | -100.0% | -100.0% | -- | -- | -- |
| 10Y Revenue / Share Growth | +208.7% | -55.0% | -- | -- | -- | -- | -- | -- | -- | -- |
| 5Y Net Income / Share Growth | -- | -- | -- | -102.1% | -- | -- | -- | -- | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | 20.6% | -430.9% | -261.3% | -317.2% | -328.9% | -367.0% | -564.7% | -595.5% |
| Net Profit Margin | 15.3% | -461.5% | -255.1% | -308.6% | -314.3% | -350.2% | -537.8% | -583.1% |
| Return on Equity (ROE) | -- | -- | -- | -- | -- | -- | -- | -327.4% |
| Return on Assets (ROA) | 122.7% | -985.2% | -318.2% | -198.6% | -151.7% | -122.2% | -110.1% | -97.0% |
| Current Ratio | 0.86x | 0.48x | 1.34x | 1.48x | 3.23x | 3.25x | 4.64x | 5.06x |
| Quick Ratio | 0.41x | 0.22x | 0.74x | 1.11x | 2.55x | 2.59x | 4.30x | 4.88x |
| Debt to Equity | -- | -- | -- | -- | -- | -- | -- | 0.12x |
| Revenue Growth (YoY) | +1232.4% | -100.0% | +8.8% | -16.3% | -10.5% | +155.6% | +6.2% | +16.3% |